NCT00487123View on ClinicalTrials.gov

Efficacy of the New Closure Device in Improving Patient Compliance in Treatment of Hypertension With Valsartan+/-Hydrochlorothiazide (HCTZ) at 6 Months

PHASE4CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
Hypertension
Interventions
DRUG

Valsartan+/- Hydrochlorothiazide

Trial Locations (1)

Unknown

Novartis Investigative Site, Singapore

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00487123 - Efficacy of the New Closure Device in Improving Patient Compliance in Treatment of Hypertension With Valsartan+/-Hydrochlorothiazide (HCTZ) at 6 Months | Biotech Hunter | Biotech Hunter